Closed tender · Chile · Public tender

Principio Activo Pembrolizumab O Nivolumab 1000022483

In EnglishActive ingredient pembrolizumab or nivolumab 1000022483

Central de Abastecimiento Del Sistema Nacional de Servicio de Salud

Central de Abastecimiento Del Sistema Nacional de Servicio de Salud in Chile invited bids for “Active ingredient pembrolizumab or nivolumab 1000022483”. Bids closed on 9 October 2026, 16:00 GMT−3; the estimated value is CLP 37.34 billion.